The Center for Breakthrough Medicines (CBM) has appointed John Lee, Ph.D. to vice president, head of Cell Therapy.   Dr. Lee is an accomplished CAR-T immunobiologist with over 20 years of cancer cell biology expertise spanning small and large molecules, as well as cell-based therapeutics.   Among his accomplishments, Lee possesses more than 15 years of clinical research and cell therapy experience including positions of increasing responsibility at The Wistar Institute, Janssen Pharmaceutica...